105 related articles for article (PubMed ID: 23998754)
21. The use of type 1 collagen scaffold containing stromal cell-derived factor-1 to create a matrix environment conducive to partial-thickness cartilage defects repair.
Zhang W; Chen J; Tao J; Jiang Y; Hu C; Huang L; Ji J; Ouyang HW
Biomaterials; 2013 Jan; 34(3):713-23. PubMed ID: 23107295
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L-lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo.
Li B; Yang J; Ma L; Li F; Tu Z; Gao C
J Biomed Mater Res A; 2013 Nov; 101(11):3097-108. PubMed ID: 23529956
[TBL] [Abstract][Full Text] [Related]
23. In vitro response of the bone marrow-derived mesenchymal stem cells seeded in a type-I collagen-glycosaminoglycan scaffold for skin wound repair under the mechanical loading condition.
Kobayashi M; Spector M
Mol Cell Biomech; 2009 Dec; 6(4):217-27. PubMed ID: 19899445
[TBL] [Abstract][Full Text] [Related]
24. The use of nanotechnology in tendon regeneration and repair.
Oragui E; Sachinis N; Hope N; Khan WS; Adesida A
J Stem Cells; 2012; 7(2):121-6. PubMed ID: 23550351
[TBL] [Abstract][Full Text] [Related]
25. The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice.
Ji R; Zhang N; You N; Li Q; Liu W; Jiang N; Liu J; Zhang H; Wang D; Tao K; Dou K
Biomaterials; 2012 Dec; 33(35):8995-9008. PubMed ID: 22985996
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
Wang J; Liao L; Tan J
Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
[TBL] [Abstract][Full Text] [Related]
27. Fibrin glue with autogenic bone marrow mesenchymal stem cells for urethral injury repair in rabbit model.
Wang K; Guan Y; Liu Y; Zhu M; Li T; An D; Ou L; Che Y; Zhang G; Zhang J; Zheng XL; Kong D
Tissue Eng Part A; 2012 Dec; 18(23-24):2507-17. PubMed ID: 22779425
[TBL] [Abstract][Full Text] [Related]
28. The growth and delivery of mesenchymal and limbal stem cells using copolymer polyamide 6/12 nanofiber scaffolds.
Holan V; Javorkova E; Trosan P
Methods Mol Biol; 2013; 1014():187-99. PubMed ID: 23690014
[TBL] [Abstract][Full Text] [Related]
29. From tendon to nerve: an MSC for all seasons.
Jamnig A; Lepperdinger G
Can J Physiol Pharmacol; 2012 Mar; 90(3):295-306. PubMed ID: 22375931
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cell therapies in the treatment of musculoskeletal diseases.
Bashir J; Sherman A; Lee H; Kaplan L; Hare JM
PM R; 2014 Jan; 6(1):61-9. PubMed ID: 24439148
[TBL] [Abstract][Full Text] [Related]
31. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
Caplan AI
J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration.
Xie X; Wang Y; Zhao C; Guo S; Liu S; Jia W; Tuan RS; Zhang C
Biomaterials; 2012 Oct; 33(29):7008-18. PubMed ID: 22818985
[TBL] [Abstract][Full Text] [Related]
33. Reconstruction of segmental bone defects in the rabbit ulna using periosteum encapsulated mesenchymal stem cells-loaded poly (lactic-co-glycolic acid) scaffolds.
Zhang X; Qi YY; Zhao TF; Li D; Dai XS; Niu L; He RX
Chin Med J (Engl); 2012 Nov; 125(22):4031-6. PubMed ID: 23158138
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of hESC-MSCs in knitted silk-collagen scaffold for tendon tissue engineering and their roles.
Chen JL; Yin Z; Shen WL; Chen X; Heng BC; Zou XH; Ouyang HW
Biomaterials; 2010 Dec; 31(36):9438-51. PubMed ID: 20870282
[TBL] [Abstract][Full Text] [Related]
35. Engineered scaffold-free tendon tissue produced by tendon-derived stem cells.
Ni M; Rui YF; Tan Q; Liu Y; Xu LL; Chan KM; Wang Y; Li G
Biomaterials; 2013 Mar; 34(8):2024-37. PubMed ID: 23246065
[TBL] [Abstract][Full Text] [Related]
36. In vivo bioluminescence imaging of magnetically targeted bone marrow-derived mesenchymal stem cells in skeletal muscle injury model.
Nakabayashi A; Kamei N; Sunagawa T; Suzuki O; Ohkawa S; Kodama A; Kamei G; Ochi M
J Orthop Res; 2013 May; 31(5):754-9. PubMed ID: 23192745
[TBL] [Abstract][Full Text] [Related]
37. The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration.
Shen W; Chen X; Chen J; Yin Z; Heng BC; Chen W; Ouyang HW
Biomaterials; 2010 Oct; 31(28):7239-49. PubMed ID: 20615544
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
[TBL] [Abstract][Full Text] [Related]
39. Alginate scaffolds for mesenchymal stem cell cardiac therapy: influence of alginate composition.
Ceccaldi C; Fullana SG; Alfarano C; Lairez O; Calise D; Cussac D; Parini A; Sallerin B
Cell Transplant; 2012; 21(9):1969-84. PubMed ID: 22776769
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later.
Trivedi P; Tray N; Nguyen T; Nigam N; Gallicano GI
Stem Cells Dev; 2010 Jul; 19(7):1109-20. PubMed ID: 20092388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
